Hongchuang Xu

Beijing, 100034, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Fluorogenic Heterodimers Enable Rapid Fluorescence Lifetime Imaging of Prostate-Specific Membrane Antigen-Positive Tumors.

Fluorogenic Heterodimers Enable Rapid Fluorescence Lifetime Imaging of Prostate-Specific Membrane Antigen-Positive Tumors.

Journal: ACS sensors
Published: April 21, 2026

Development of a Novel 68Ga-Labeled Radiotracer Targeting Carbonic Anhydrase IX for the Diagnosis of Clear Cell Renal Cell Carcinoma.

Development of a Novel 68Ga-Labeled Radiotracer Targeting Carbonic Anhydrase IX for the Diagnosis of Clear Cell Renal Cell Carcinoma.

Journal: Molecular pharmaceutics
Published: February 02, 2026

Development of a novel 18F-labeled radiotracer targeting granzyme B for imaging early tumor responses to immunotherapy.

Development of a novel 18F-labeled radiotracer targeting granzyme B for imaging early tumor responses to immunotherapy.

Journal: Journal for immunotherapy of cancer
Published: October 28, 2025

First-in-human Study of a Dual-modality Prostate-specific Membrane Antigen-targeted Probe for Preoperative Positron Emission Tomography/Computed Tomography Imaging and Intraoperative Fluorescence Imaging in Prostate Cancer.

First-in-human Study of a Dual-modality Prostate-specific Membrane Antigen-targeted Probe for Preoperative Positron Emission Tomography/Computed Tomography Imaging and Intraoperative Fluorescence Imaging in Prostate Cancer.

Journal: European urology
Published: January 09, 2025

Preclinical Evaluation of an Al18F-Radiolabeled Bicyclic Peptide Targeting Nectin-4.

Preclinical Evaluation of an Al18F-Radiolabeled Bicyclic Peptide Targeting Nectin-4.

Journal: Molecular pharmaceutics
Published: December 09, 2024

Rational modifications on N-(4-quinolinoyl)-Gly-2-cyanopyrrolidine to develop fibroblast activation protein-targeted radioligands with improved affinity and tumor uptake.

Rational modifications on N-(4-quinolinoyl)-Gly-2-cyanopyrrolidine to develop fibroblast activation protein-targeted radioligands with improved affinity and tumor uptake.

Journal: European journal of medicinal chemistry
Published: September 06, 2024

Early detection of anthracycline-induced cardiotoxicity using [68 Ga]Ga-FAPI-04 imaging.

Early detection of anthracycline-induced cardiotoxicity using [68 Ga]Ga-FAPI-04 imaging.

Journal: European journal of nuclear medicine and molecular imaging
Published: December 14, 2023

Granzyme B PET imaging inflammation and remodeling in myocardial infarction.

Granzyme B PET imaging inflammation and remodeling in myocardial infarction.

Journal: European journal of nuclear medicine and molecular imaging
Published: August 03, 2023

Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer.

Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer.

Journal: Cancer cell
Published: January 12, 2023

Noninvasive interrogation of CD8+ T cell effector function for monitoring early tumor responses to immunotherapy.

Noninvasive interrogation of CD8+ T cell effector function for monitoring early tumor responses to immunotherapy.

Journal: The Journal of clinical investigation
Published: April 14, 2022

Optimization of ODAP-Urea-based dual-modality PSMA targeting probes for sequential PET-CT and optical imaging.

Optimization of ODAP-Urea-based dual-modality PSMA targeting probes for sequential PET-CT and optical imaging.

Journal: Bioorganic & medicinal chemistry
Published: March 24, 2022

A self-triggered radioligand therapy agent for fluorescence imaging of the treatment response in prostate cancer.

A self-triggered radioligand therapy agent for fluorescence imaging of the treatment response in prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging
Published: November 24, 2021
Showing 1-12 of 12

Last Updated: 09/26/2026